Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ABO Blood Type Incompatible Kidney Transplantation”

3 trials

Showing 3 of 3 results

Testing effectiveness (Phase 2)Ended earlyNCT01095887
What this trial is testing

Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation

Who this might be right for
Kidney Transplant
Mayo Clinic 6
Not applicableStudy completedNCT04541914
What this trial is testing

Diagnostic Efficacy of Molecular Diagnostic Method for AMR in ABOiKT

Who this might be right for
ABO Blood Type Incompatible Kidney TransplantationAntibody-mediated Rejection
Seoul National University Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06453135
What this trial is testing

Eculizumab for Prevention of Antibody-Mediated Rejection in ABO-Incompatible Living Donor Kidney Transplantation

Who this might be right for
Kidney Transplantation
Tao Lin 30

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation